Synthesis of 3,3-Bis(3-fluorophenyl)-[2,3-3h2]-1-propanamine Hydrochloride ([3H2]-NPS 846 · HCl): A novel ligand for the NMDA receptor

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 41, Issue 6, 1998, Pages 535-543

  Moe, Scott T ^a   Smith, Daryl L ^a   By, Kolbot ^a   Egan, Judith A ^b   Filer, Crist N ^b  

^a NPS Pharmaceutical Inc   (United States)

^b NEN Life Science Products Inc ^*  (United States)

Author keywords

Catalytic tritiation; NMDA receptor antagonists; 3H2 NPS 846 HCl

Indexed keywords

CATALYTIC TRITIATION; NMDA RECEPTOR; NMDA RECEPTOR ANTAGONIST; NOVEL LIGANDS; REACTION SEQUENCES; RECEPTOR ANTAGONISTS; SYNTHESISED; TRITIATION; TWO-COMPONENT; [3H2]-NPS 846 · HCL;

LIGANDS;

3,3 BIS(3 FLUOROPHENYL) 1 PROPANAMINE; DEUTERIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NPS 846; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DRUG SYNTHESIS; ISOTOPE TRACING; LIGAND BINDING; RADIOCHEMISTRY; RECEPTOR INTRINSIC ACTIVITY; STRUCTURE ANALYSIS;

TRITIUM;

EID: 0031746028     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1344(199806)41:6<535::AID-JLCR101>3.0.CO;2-P     Document Type: Article

References (18)

1. Mueller, A.L.; VanWagenen, B.C.; DelMar, E.G.; Balandrin, M.F.; Moe, S.T.; and Artman, L.D.-Arylalkylamine compounds active at a novel site on receptor-operated calcium channels useful for the treatment of neurological disorders and diseases, and preparation of these compounds. PCT Internatl. Appl. WO 95/21,612 (August 17, 1995); U.S. Patent Appl. 14,813 (February 8, 1993), 139 pp.; Chem. Abstr. 123(23): P 306618t (1995).
2. Balandrin, M.F.; VanWagenen, B.C.; DelMar, E.G.; Artman, L.D.; and Mueller, A.L.-Discovery, design, and in vitro biological evaluation of NPS 846 and its congeners: Novel NMDA receptor antagonists. 37th Annual Meeting of the American Society of Pharmacognosy, O19, University of California, Santa Cruz, California, July 27-31, 1996.
3. VanWagenen, B.C.; Balandrin, M.F.; DelMar, E.G.; Artman, L.D.; and Mueller, A.L.-Design, synthesis and biological evaluation of NPS 846 hydrochloride, a novel antagonist at the NMDA receptor. 212th National Meeting of the American Chemical Society, ORGN 273, Orlando, Florida, August 25-29, 1996.
4. Artman, L.D.; VanWagenen, B.C.; Balandrin, M.F.; DelMar, E.G.; Hammerland, L.G.; Donovan, S.D.: Rogawski, M.A.; Williams, K.; and Mueller, A.L.-NPS 846·HCl, a novel open-channel blocker of the NMDA receptor: in vitro characterization. Soc. Neurosci. Abstr. 22, Part 2: 1282, 508.8 (1996).
5. Mueller, A.L.; Artman, L.D.; Li, H.; Balster, R.L.; Taylor, D.; and Parks, T.N.-NPS 846·HCl, a novel open-channel blocker of the NMDA receptor: in vivo characterization. Soc. Neurosci. Abstr. 22, Part 2: 1282, 508.9 (1996).
6. Chien, Y.; Raskiewicz, J.L.; Draper. S.; White, H.S.; and Mueller, A.L.-Neuroprotectant and anticonvulsam properties of NPS 846·HCl, a novel NMDA receptor antagonist. Soc. Neurosci. Abstr. 22, Part 2: 1282, 508.10 (1996).
7. Mueller, A.L.; Moe, S.T.; Balandrin, M.F.; Delmar, E.G.; Van Wagenen, B.C.; Artman, L.D.; Barmore, R.M.; and Smith, D.L.-Compounds active at a novel site on receptor operated calcium channels useful for treatment of neurological disorders: Preparation of 1-amino-3,3-diphenylpropanes and related compounds as noncompetative antagonists of glutamate receptor-operated calcium channels in the central nervous system. PCT Internatl. Appl. WO 96/40,097 (December 19, 1996); U.S. Patent Appl. 08/485,038 (June 7, 1995), 313 pp.; Chem. Abstr. 126: P 143970 (1995).
8. Watkins, J.E.; and Evans, R.H.-Excitatory amino acid transmitters. Annu. Rev, Pharmacol. Toxicol. 21: 165-204 (1981).
9. Foster, A.C.; and Fagg, G.E.-Acidic amino acid binding sites in mammalian neuronal membranes: Their characteristics and relationship to synaptic receptors. Brain Res. Rev. 7: 103-104 (1984).
10. Choi, D.W.-Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634 (1988).
11. MacDermott, A.B.; Mayer, M.L.; Westbrook, G.L.; Smith, S.J.; and Barker, J.L.-NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 321: 519-522 (1986).
12. Schanne, F.A.; Kane A.B.; Young, E.E.; and Farber, J.L.-Calcium dependence of toxic cell death: A final common pathway. Science 206: 700-702 (1979).
13. Meldrum, B.S.; and Chapman, A.G.-Competitive NMDA antagonists as drugs. In: Collingridge G.L. and Watkins J.C. (Eds.), The NMDA Receptor, 2nd ed., Oxford University Press, NY, 1994, pp. 457-468.
14. Evans, E. A.-Tritium and Its Compounds, Van Nostrand Co., Princeton, NJ, 1966, pp. 139-144.
15. Marton, J.; and Kovacs, A.-Heterogenous catalytic exchange reaction between tritium gas and the solvent in the catalytic tritiation of saturated compounds. Radioisotopy 12(4), 595-604 (1971); see also [Chem. Abstr. 76: 104285 (1971)].
16. Marton, J.; and Kovacs, A.-Heterogenous catalytic exchange reaction between tritium gas and the solvent in the catalytic tritiation of saturated compounds. Radioisotopy 12(4), 595-604 (1971); see also [Chem. Abstr. 76: 104285 (1971)].
17. Hanus, J.; Cemy, B.; and Benes, J.-The [sic] tritium incorporation into the [sic] solvents under conditions of catalytic hydrogenation. J. Labelled Compds. 10: 523-531 (1974).
18. Silverstein, R.M.; Bassler, G.C.; and Morrill, T.C.-Spectrometric Identification of Organic Compounds, 5th ed., John Wiley & Sons, NY, 1991, p 10.